CD274 and neoplasm: The results demonstrated that in vivo treatment of tumor-bearing mice with M3R blocker, 4-DAMP, significantly reduced the expression of PD-L1 compared to DMSO-treated controls (Figure 5A,D and Figure S1A’,B’, ∆: −22.88 ± 0.80, p < 0.0001).